These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21962616)

  • 1. Polycystic kidney disease presenting with hypertension and hypokalemia.
    Chow KM; Ma RC; Szeto CC; Li PK
    Am J Kidney Dis; 2012 Feb; 59(2):270-2. PubMed ID: 21962616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 22-year-old woman with hypertension and hypokalemia due to a juxtaglomerular cell tumor.
    Ossareh S; Shooshtarizadeh T; Shadpour P
    Iran J Kidney Dis; 2011 Nov; 5(6):425-8. PubMed ID: 22057077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aliskiren corrects recurrent hyperreninemia and hyperaldosteronism in autosomal dominant polycystic kidney disease.
    Amico P; Kalbermatter S; Kiss D
    Clin Nephrol; 2009 Sep; 72(3):237-9. PubMed ID: 19761733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
    Ecder T; Schrier RW
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):369-74. PubMed ID: 15151483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aliskiren: a novel renin inhibitor for hypertension.
    Parmar DM; Jadav SP
    Indian J Physiol Pharmacol; 2007; 51(1):99-101. PubMed ID: 17877301
    [No Abstract]   [Full Text] [Related]  

  • 6. Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.
    Masoumi A; Elhassan E; Schrier RW
    Iran J Kidney Dis; 2011 Jan; 5(1):1-8. PubMed ID: 21189426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months.
    De Almeida EA; Prata MM
    Rev Port Cardiol; 2007 Nov; 26(11):1173-82. PubMed ID: 18297839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
    Chapman AB; Johnson A; Gabow PA; Schrier RW
    N Engl J Med; 1990 Oct; 323(16):1091-6. PubMed ID: 2215576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE gene I/D polymorphism and the presence of renal failure or hypertension in autosomal dominant polycystic kidney disease (ADPKD).
    Gumprecht J; Zychma MJ; Karasek D; Grzeszczak W
    Nephrol Dial Transplant; 2007 May; 22(5):1483. PubMed ID: 17205958
    [No Abstract]   [Full Text] [Related]  

  • 11. Aliskiren: an oral renin inhibitor for the treatment of hypertension.
    Lam S; Choy M
    Cardiol Rev; 2007; 15(6):316-23. PubMed ID: 18090068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renin inhibitors--new direction in the treatment of arterial hypertension].
    Vasiuk IuA; Sadulaeva IA; Iushchuk EN; Trofimenko OS; Chirkov MV; Fedoseeva VS; Kulikov KG
    Ter Arkh; 2010; 82(9):53-9. PubMed ID: 21086622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal care of autosomal dominant polycystic kidney disease patients.
    Schrier RW
    Nephrology (Carlton); 2006 Apr; 11(2):124-30. PubMed ID: 16669974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aliskiren for hypertension in adults.
    Drug Ther Bull; 2008 Oct; 46(10):73-6. PubMed ID: 18832257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
    Gradman AH; Traub D
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S22-30. PubMed ID: 17401313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension in autosomal dominant polycystic kidney disease.
    Chapman AB; Gabow PA
    Kidney Int Suppl; 1997 Oct; 61():S71-3. PubMed ID: 9328971
    [No Abstract]   [Full Text] [Related]  

  • 18. It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia.
    Brambilla G; Perotti M; Perra S; Dell'Oro R; Grassi G; Pincelli AI
    J Nephrol; 2013; 26(3):594-8. PubMed ID: 23475471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.
    Gradman AH; Weir MR; Wright M; Bush CA; Keefe DL
    J Hum Hypertens; 2010 Nov; 24(11):721-9. PubMed ID: 20200550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
    Gattone VH; Siqueira TM; Powell CR; Trambaugh CM; Lingeman JE; Shalhav AL
    Exp Biol Med (Maywood); 2008 Aug; 233(8):952-7. PubMed ID: 18480417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.